Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03290430 · ClinicalTrials.gov registry record · Early Phase 1
End Nicotine Dependence Clinic
A Early Phase 1 study of Smoking Cessation, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT03290430: Completed Early Phase 1 study of Smoking Cessation, sponsored by Case Comprehensive Cancer Center.
NCT03290430 is a Early Phase 1 study of Smoking Cessation that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 56 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03290430, a Early Phase 1 study of Smoking Cessation, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to study a smoking cessation program for adult smokers in Northeast Ohio. The study will also look at how different people respond to the program.
Primary Outcome
Number of participants who did not smoke for 24 hours. Coded as binary (1 = cessation, 0 = smoking)
Conditions Studied
Interventions
- BEHAVIORAL Individual Counseling
- BEHAVIORAL Group Counseling
- BEHAVIORAL Phone Counseling
- BEHAVIORAL Video Counseling
- BEHAVIORAL Texting support
Study Locations (1)
Ohio
- Case Western Reserve University, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2018-01-09 |
| Est. Completion | 2020-01-06 |
| Phase | Early Phase 1 |
What the finished NCT03290430 record still lists
NCT03290430 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 5 interventions - of which Individual Counseling is the first listed.
NCT03290430 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03290430 about?
NCT03290430 is a clinical study titled "End Nicotine Dependence Clinic". The purpose of this research is to study a smoking cessation program for adult smokers in Northeast Ohio. The study will also look at how different people respond to the program.
What is the current status of trial NCT03290430?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 56 participants. The study started on 2018-01-09. Estimated completion is 2020-01-06.
What conditions does trial NCT03290430 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT03290430?
The interventions under investigation include: Individual Counseling (BEHAVIORAL), Group Counseling (BEHAVIORAL), Phone Counseling (BEHAVIORAL), Video Counseling (BEHAVIORAL), Texting support (BEHAVIORAL).
Who is sponsoring clinical trial NCT03290430?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03290430 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03290430's enrollment target sits among peer trials
56 140th of 188 higher than 49 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
Smoking Cessation Treatment for Head & Neck Cancer Patients
ACTIVE NOT RECRUITING · Early Phase 1
-
Hollings Cancer Center Varenicline Sampling Study
COMPLETED · Early Phase 1
-
Applying mHealth to Tobacco-related Health Disparities
COMPLETED · Early Phase 1
-
Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
COMPLETED · Early Phase 1
-
Smoking by IV Pulsed Nicotine
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI